Article Versions Notes

Tsiakalos A, Ziakas PD, Polyzou E, Schinas G, Akinosoglou K. Early Fluvoxamine Reduces the Risk for Clinical Deterioration in Symptomatic Outpatients with COVID-19: A Real-World, Retrospective, before–after Analysis. Microorganisms. 2023; 11(8):2073. https://doi.org/10.3390/microorganisms11082073

Tsiakalos, Aristotelis, Panayiotis D. Ziakas, Eleni Polyzou, Georgios Schinas, and Karolina Akinosoglou. 2023. "Early Fluvoxamine Reduces the Risk for Clinical Deterioration in Symptomatic Outpatients with COVID-19: A Real-World, Retrospective, before–after Analysis" Microorganisms 11, no. 8: 2073. https://doi.org/10.3390/microorganisms11082073

Tsiakalos, A., Ziakas, P. D., Polyzou, E., Schinas, G., & Akinosoglou, K. (2023). Early Fluvoxamine Reduces the Risk for Clinical Deterioration in Symptomatic Outpatients with COVID-19: A Real-World, Retrospective, before–after Analysis. Microorganisms, 11(8), 2073. https://doi.org/10.3390/microorganisms11082073